Portrait of Prof. Ahlam Zaid Alkilani, Dean of Scientific Research at Zarqa University, Professor of Pharmaceutical Technology.

About me

Prof. Ahlam Zaid Alkilani is the Dean of Scientific Research at Zarqa University, Jordan, and a Professor of Pharmaceutical Technology. She holds a Ph.D. from Queen’s University Belfast, UK, and specializes in drug delivery and pharmaceutical technology. Her achievements include the L’Oréal–UNESCO For Women in Science Levant Young Talents Award, TWAS Young Affiliate recognition, the Stanford–Elsevier Top 2% Scientists ranking, and the Royal Academy of Engineering Leaders in Innovation Fellowships. She is the Founder and Chair of the Women in Science Initiative at Zarqa University, promoting research excellence, women's empowerment, innovation, and international collaboration.

Prof. Ahlam Zaid Alkilani is currently the Dean of Scientific Research at Zarqa University, Jordan, where she leads initiatives to advance research excellence, innovation, international collaboration, and women in science. She is a Professor of Pharmaceutical Technology with extensive experience in pharmaceutical research, academic leadership, postgraduate education, and research development.
Prof. Alkilani obtained her Ph.D. in Pharmaceutical Technology from Queen’s University Belfast, United Kingdom, in 2013. Her doctoral research focused on Polymeric Microneedle Systems for Enhanced Transdermal Drug Delivery.
Following the completion of her doctoral studies, she returned to Zarqa University and progressed through several academic and administrative positions, including Head of the Department of Pharmaceutical Sciences and Pharmaceutics, Deputy Dean, and Dean of the School of Pharmacy.
Her achievements include being selected as one of the recipients of the L’Oréal–UNESCO For Women in Science Levant Young Talents Award in 2024, with the award presented in 2025, and being named a TWAS Young Affiliate for the 2023–2028 period. She was also recognized among the world’s top 2% of scientists in the Stanford University–Elsevier ranking in 2024 and selected for the 2026 edition. In 2025, she was awarded a place in the Royal Academy of Engineering’s Leaders in Innovation Fellowships (LIF) Global programme 2025, supporting the development and translation of innovative research into practical applications.
In addition to her research activities, Prof. Alkilani has made substantial contributions to pharmaceutical education and postgraduate training. She played a key role in establishing and developing master’s programmes at the School of Pharmacy, Zarqa University, beginning in 2018. She has supervised master’s students, led research projects, and served on numerous master’s and Ph.D. dissertation committees. In her current role as Dean of Scientific Research, she is committed to strengthening the university’s research ecosystem, supporting early-career researchers, promoting interdisciplinary and international research partnerships, increasing the visibility and impact of scholarly publications, and fostering innovation and knowledge transfer.

Degrees:

2013
Doctorate
Medical and Health Sciences incl Neurosciences
2009
Master
Medical and Health Sciences incl Neurosciences
2006
Undergraduate
Medical and Health Sciences incl Neurosciences

Publications resulting from Research
Publications

1. Yusoh, N. A., Azil, A., Alkilani, A. Z., Rahman, M. B. A., Asmawi, A. A., Razali, R., ... & Kamal, N. A. M. A. (2026). Repurposing Non-oncologic Drugs via Targeted Nanocarriers for Cancer Therapy: Mechanisms, Synergistic Combinations, and Clinical Translation. AAPS PharmSciTech, 27(5), 248.
2. HASAN, I., KHANFAR, M., & ALKILANI, A. Z. (2026). Amorphous Solid Dispersion-Based Dissolving Microneedles for Transdermal Delivery of Ivacaftor. Int J App Pharm, 18(5), 323-340.
3. Al-Shawabkeh, H. F., Aburayya, R., Basheer, H. A., Zaid Alkilani, A., Alhusban, M. A., & Hamed, R. (2026). Fabrication and Characterization of Green-Synthesized Zinc Oxide Nanoparticles Loaded into Dissolving Microneedles: A Potential Delivery Platform for Breast Cancer Therapy. ACS omega, 11(36), 53725-53744.
4. Alkilani, A. Z., Basheer, H. A., Alhusban, M. A., & Alshaer, W. (2025). Niosomal co-delivery of metformin and telaglenastat: A targeted nanotherapeutic strategy for breast cancer treatment and metastasis suppression in 2D and 3D models. Biomedicine & Pharmacotherapy, 193, 118843.
5. Basheer, H. A., Alkilani, A. Z., Bashir, S. A., Alhusban, M. A., Elsalem, L., AlOmari, S. B., ... & Afarinkia, K. (2025). Clinicopathological analysis of GLUT-1, GLS1, and GLS2 expression in breast cancer tissues from Jordanian patients. Scientific Reports, 15(1), 34135.
6. Hamed, R., Alkilani, A. Z., Al-Adhami, Y., Musleh, B., & Aburayya, R. (2025). Advances in Transdermal Delivery Systems for Antifungals: Current Approaches and Future Perspectives. Microbial Pathogenesis, 107776.
7. Hamed, R., Aburayya, R., Alkilani, A. Z., Hammad, A. M., Abusara, O. H., & Abo-Zour, H. (2025). Thermo-Responsive Niosomal In Situ Gels for Topical Delivery of Prednisolone. AAPS PharmSciTech, 26(5), 1-28.
8. Basheer, H. A., Alkilani, A. Z., Alhusban, M. A., Abo-Zour, H., & Alshaer, W. (2025). Evaluating Niosomes Cytotoxicity on Fibroblast Cells: A Preliminary Step Towards Cancer Cell Assessment Using Telaglenastat as a Model Drug. BioNanoScience, 15(1), 1-16.
9. Jaber, D., Salman, N., Al Tabbah, S., El-Sharif, A. R., Alkilani, A. Z., & Qourshah, A. (2025). Evaluating the Knowledge, Attitude, and Practices of Jordanian Society Towards Halal Pharmaceuticals. The Open Public Health Journal, 18(1).
10. Zaid Alkilani, A., Hamed, R., Musleh, B., & Sharaire, Z. (2024). Breaking boundaries: the advancements in transdermal delivery of antibiotics. Drug Delivery, 31(1), 2304251.
11. Zaid Alkilani, A., Alkhaldi, R. A., Basheer, H. A., Amro, B. I., & Alhusban, M. A. (2025). Fabrication of thymoquinone and ascorbic acid-loaded spanlastics gel for hyperpigmentation: in vitro release, cytotoxicity, and skin permeation studies. Pharmaceutics, 17(1), 48.
12. Hamed, R., AbuKwiak, A. D., Aburayya, R., Alkilani, A. Z., Hamadneh, L., Naser, M., ... & Alhusban, A. A. (2024). Microneedles Mediated-Dermal Delivery of Vitamin C: Formulation, Characterization, Cytotoxicity, and Enhancement of Stability. Heliyon.
13. Al-Nimry, S. S., Alkilani, A. Z., & Alda’ajeh, N. A. (2024). Transdermal drug delivery of rizatriptan using microneedles array patch: preparation, characterization and ex-vivo/in-vivo study. Pharmaceutical Development and Technology, 29(7), 776-789.
14. Alkilani, A. Z., Omar, S., Nasereddin, J., Hamed, R., & Obeidat, R. (2024). Design of colon-targeted drug delivery of dexamethasone: Formulation and in vitro characterization of solid dispersions. Heliyon, 10(14).
15. Alkilani, A. Z., Sharaire, Z., Hamed, R., & Basheer, H. A. (2024). Transdermal Delivery System of Doxycycline-Loaded Niosomal Gels: Toward Enhancing Doxycycline Stability. ACS Omega.
16. Jaber, D., Hasan, H. E., Alkaderi, A., Alkilani, A. Z., & El-Sharif, A. R. (2024). Assessment of the Knowledge, Attitude, and Perception of Healthcare Providers Regarding Halal Pharmaceuticals. The Open Public Health Journal, 17(1).
17. Hamed, R., Abu Nahia, B. J., Alkilani, A. Z., Al-Adhami, Y., & Obaidat, R. (2024). Recent Advances in Microneedling-Assisted Cosmetic Applications. Cosmetics, 11(2), 51.
18. Zaid Alkilani, A., Hamed, R., Musleh, B., & Sharaire, Z. (2024). Breaking boundaries: the advancements in transdermal delivery of antibiotics. Drug Delivery, 31(1), 2304251.
19. Nasereddin, J., Al Wadi, R., Zaid Al-Kilani, A., Abu Khalil, A., Al Natour, M., & Abu Dayyih, W. (2024). The Use of Data Mining for Obtaining Deeper Insights into the Fabrication of Prednisolone-Loaded Chitosan Nanoparticles. AAPS PharmSciTech, 25(2), 38.
20. Nasereddin, J., Al-Wadi, R., Alkilani, A. Z., Nahia, B. A., Hailat, M. M., & Dayyih, W. A. (2024). Optimization and Validation of Spectrophotometric Methods for the Determination of Prednisolone in Chitosan Nanoparticles. Journal of Hunan University Natural Sciences, 51(4).
21. Basheer, H.A., Alhusban, M.A., Zaid Alkilani, A., Alshishani, A., Elsalem, L. and Afarinkia, K., 2023. Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment. Cancers, 15(20), p.5004.
22. Zaid Alkilani, A., Abo-Zour, H., Basheer, H. A., Abu-Zour, H., & Donnelly, R. F. (2023). Development and Evaluation of an Innovative Approach Using Niosomes Based Polymeric Microneedles to Deliver Dual Antioxidant Drugs. Polymers, 15(8), 1962.
23. Zaid Alkilani, A., Musleh, B., Hamed, R., Swellmeen, L., & Basheer, H. A. (2023). Preparation and Characterization of Patch Loaded with Clarithromycin Nanovesicles for Transdermal Drug Delivery. Journal of Functional Biomaterials, 14(2), 57.
24. Zaid Alkilani, A., Abu-Zour, H., Alshishani, A., Abu-Huwaij, R., Basheer, H. A., & Abo-Zour, H. (2022). Formulation and evaluation of niosomal alendronate sodium encapsulated in polymeric microneedles: In vitro studies, stability study and cytotoxicity study. Nanomaterials, 12(20), 3570.
25. Alkilani, A.Z, Hamed, R., Abdo, H., Swellmeen, L., Basheer, H. A., Wahdan, W., & Abu Kwiak, A. D. (2022). Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study. ACS omega.
26. Alkilani, A.Z, Nimrawi, S., Al-Nemrawi, N. K., & Nasereddin, J. (2022). Microneedle-assisted transdermal delivery of amlodipine besylate loaded nanoparticles. Drug Development and Industrial Pharmacy, 1-11.
27. Alkilani, A. Z., Nasereddin, J., Hamed, R., Nimrawi, S., Hussein, G., Abo-Zour, H., & Donnelly, R. F. (2022). Beneath the Skin: A Review of Current Trends and Future Prospects of Transdermal Drug Delivery Systems. Pharmaceutics, 14(6), 1152.
28. Alkilani, A., Hamed, R., Hussein, G., & Alnadi, S. (2021). Nanoemulsion-based patch for the dermal delivery of ascorbic acid. Journal of Dispersion Science and Technology, 1-11.
29. Hamed, R., Mahmoud, N. N., Alnadi, S. H., Alkilani, A. Z., & Hussein, G. (2020). Diclofenac diethylamine nanosystems-loaded bigels for topical delivery: development, rheological characterization, and release studies. Drug Development and Industrial Pharmacy, 46(10), 1705-1715.
30. Hamed, R., Kamal, A., & Alkilani, A. Z. (2020). Gelation and rheological characterization of Carbopol® in simulated gastrointestinal fluid of variable chemical properties. Pakistan Journal of Pharmaceutical Sciences, 33(3).
31. Alkilani, A. Z., Alkalbani, R., Jaber, D., Hamed, R., Hamad, I., Abumansour, H., & Assab, M. A. (2019). Knowledge, attitude, practice and satisfaction of patients using analgesic patches in Jordan. Tropical Journal of Pharmaceutical Research, 18(8).
32. Development and in-vitro characterization of nanoemulsion-based buccal patches of valsartan , Abu-Huwaij, R. Hamed, R., Daoud , E., Alkilani, A. Z., Acta Poloniae Pharmaceutica, Vol. 76 No. 2 , 2019

33. Alkilani, A. Z., Hamed, R., Al-Marabeh, S., Kamal, A., Abu-Huwaij, R., & Hamad, I. (2018). Nanoemulsion-based film formulation for transdermal delivery of carvedilol. Journal of Drug Delivery Science and Technology, 46, 122-128.

34. Hamed, R., Al Baraghthi, T., Alkilani, A. Z., & Abu-Huwaij, R. (2016). Correlation between rheological properties and in vitro drug release from penetration enhancer-loaded Carbopol® gels. Journal of Pharmaceutical Innovation, 11(4), 339-351.

35. Eltayib, E., Brady, A. J., Caffarel-Salvador, E., Gonzalez-Vazquez, P., Alkilani, A. Z., McCarthy, H. O., ... & Donnelly, R. F. (2016). Hydrogel-forming microneedle arrays: potential for use in minimally-invasive lithium monitoring. European Journal of Pharmaceutics and Biopharmaceutics, 102, 123-131.

36. Alkilani, A., McCrudden, M. T., & Donnelly, R. (2015). Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics, 7(4), 438-470.


37. McCrudden, M. T., Alkilani, A. Z., Courtenay, A. J., McCrudden, C. M., McCloskey, B., Walker, C., ... & Donnelly, R. F. (2015). Considerations in the sterile manufacture of polymeric microneedle arrays. Drug delivery and translational research, 5(1), 3-14.

38. Donnelly, R. F., McCrudden, M. T., Alkilani, A. Z., Larrañeta, E., McAlister, E., Courtenay, A. J., ... & Caffarel-Salvador, E. (2014). Hydrogel-forming microneedles prepared from “super swelling” polymers combined with lyophilised wafers for transdermal drug delivery. PLoS One, 9(10), e111547.


39. Donnelly, R. F., Moffatt, K., Alkilani, A. Z., Vicente-Pérez, E. M., Barry, J., McCrudden, M. T., & Woolfson, A. D. (2014). Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet. Pharmaceutical research, 31(8), 1989-1999.

40. Donnelly, R. F., Morrow, D. I., McCrudden, M. T., Alkilani, A. Z., Vicente‐Pérez, E. M., O'Mahony, C., ... & Woolfson, A. D. (2014). Hydrogel‐forming and dissolving microneedles for enhanced delivery of photosensitizers and precursors. Photochemistry and photobiology, 90(3), 641-647.

41. McCrudden, M. T., Alkilani, A. Z., McCrudden, C. M., McAlister, E., McCarthy, H. O., Woolfson, A. D., & Donnelly, R. F. (2014). Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. Journal of controlled release, 180, 71-80.

42. Donnelly, R. F., Singh, T. R. R., Alkilani, A. Z., McCrudden, M. T., O’neill, S., O’mahony, C., ... & Woolfson, A. D. (2013). Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. International journal of pharmaceutics, 451(1-2), 76-91.